Morgan Stanley’s NeuroMetrix, Inc. Common Stock NURO Stock Holding History
Bought
Maintained
Sold
Other funds holding NURO
GS
TRCT
TAM
Morgan Stanley's NURO Position: Q4 2024 in Review
Morgan Stanley sold out of NeuroMetrix, Inc. Common Stock (NURO) in Q4 2024, closing a stake of 1 share — an estimated $4 sold.
Morgan Stanley first reported a position in NURO in Q4 2013 and held it in 11 quarters. The position peaked at $70K in Q4 2021. 16 funds tracked by Wall St. Rank hold NURO as of Q4 2024.
- Morgan Stanley reported no remaining NeuroMetrix, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
- Morgan Stanley sold 1 NeuroMetrix, Inc. Common Stock share in Q4 2024, an estimated $4.
- Morgan Stanley first reported a position in NeuroMetrix, Inc. Common Stock in Q4 2013 and held it in 11 quarters.
- Morgan Stanley's NeuroMetrix, Inc. Common Stock position peaked at $70K in Q4 2021.
- 16 funds tracked by Wall St. Rank held NeuroMetrix, Inc. Common Stock as of Q4 2024.
Based on Morgan Stanley's 13F filing for Q4 2024, filed 14 Feb 2025.